Page last updated: 2024-09-05

phosphatidylcholines and salmeterol xinafoate

phosphatidylcholines has been researched along with salmeterol xinafoate in 5 studies

Compound Research Comparison

Studies (phosphatidylcholines)	Trials (phosphatidylcholines)	Recent Studies (post-2010) (phosphatidylcholines)	Studies (salmeterol xinafoate)	Trials (salmeterol xinafoate)	Recent Studies (post-2010) (salmeterol xinafoate)
32,204	443	5,593	1,872	684	398

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Butler, R; Herbette, L; Newton, R; Rhodes, DG	1
Ayres, JG; Benincasa, C; Shaheen, MZ	1
Austin, RP; Barton, P; Davis, AM; Manners, CN; Stansfield, MC	1
Christian, C; Kresch, MJ; Kumar, VH	1
Healy, MP; Reilly, J; Sandham, DA; Shaw, DE; Wang, B; Yan, S; Yang, L	1

Trials

1 trial(s) available for phosphatidylcholines and salmeterol xinafoate

Article	Year
Incidence of acute decreases in peak expiratory flow following the use of metered-dose inhalers in asthmatic patients. The European respiratory journal, 1994, Volume: 7, Issue:12 Topics: Aerosol Propellants; Age Factors; Albuterol; Asthma; Bronchoconstriction; Bronchodilator Agents; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Nebulizers and Vaporizers; Oleic Acid; Oleic Acids; Peak Expiratory Flow Rate; Phosphatidylcholines; Salmeterol Xinafoate	1994

Article

Year

Incidence of acute decreases in peak expiratory flow following the use of metered-dose inhalers in asthmatic patients.

The European respiratory journal, 1994, Volume: 7, Issue:12

Topics: Aerosol Propellants; Age Factors; Albuterol; Asthma; Bronchoconstriction; Bronchodilator Agents; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Nebulizers and Vaporizers; Oleic Acid; Oleic Acids; Peak Expiratory Flow Rate; Phosphatidylcholines; Salmeterol Xinafoate

1994

Other Studies

4 other study(ies) available for phosphatidylcholines and salmeterol xinafoate

Article	Year
Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers. Molecular pharmacology, 1992, Volume: 42, Issue:4 Topics: Albuterol; Kinetics; Lipid Bilayers; Liposomes; Phosphatidylcholines; Salmeterol Xinafoate; Solubility; Temperature	1992
The effect of ionic strength on liposome-buffer and 1-octanol-buffer distribution coefficients. Journal of pharmaceutical sciences, 1998, Volume: 87, Issue:5 Topics: 1-Butanol; Albuterol; Buffers; Chromones; Clofibrate; Drug Carriers; Hydrogen-Ion Concentration; Liposomes; Osmolar Concentration; Phosphatidylcholines; Salmeterol Xinafoate	1998
Effects of salmeterol on secretion of phosphatidylcholine by alveolar type II cells. Life sciences, 2000, Volume: 66, Issue:17 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Epithelial Cells; L-Lactate Dehydrogenase; Male; Phosphatidylcholines; Propranolol; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Salmeterol Xinafoate	2000
Interactions between β2-Adrenoceptor Ligands and Membrane: Atomic-Level Insights from Magic-Angle Spinning NMR. Journal of medicinal chemistry, 2017, 08-24, Volume: 60, Issue:16 Topics: Adrenergic beta-2 Receptor Agonists; Formoterol Fumarate; Hydrophobic and Hydrophilic Interactions; Indans; Ligands; Liposomes; Magnetic Resonance Spectroscopy; Phosphatidylcholines; Quinolones; Salmeterol Xinafoate	2017